Experts weigh risks, benefits of testing AIDS vaccines in teens

06/10/2008 | Bloomberg

An FDA advisory panel said HIV/AIDS trials in adolescents may be appropriate in countries where adolescents are at higher risk for the disease, but said the risks may outweigh the benefits for testing in U.S. teens. The group is considering medical and ethical questions to improve research guidelines for testing a variety of therapies in clinical trials in children.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ